scPharmaceuticals Inc.
US ˙ NasdaqGS ˙ US8106481059

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Klaus R Dr Veitinger. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Klaus R Dr Veitinger har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TCDA / Tricida Inc Director 57.235
US:SCPH / scPharmaceuticals Inc. Director 16.300
US:ICPT / Intercept Pharmaceuticals Inc Director 1.750
US:RLYP / Relypsa, Inc. Director 69.543
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Klaus R Dr Veitinger. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb SCPH / scPharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SCPH / scPharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SCPH / scPharmaceuticals Inc. Insider Trades
Insidersalg SCPH / scPharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SCPH / scPharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SCPH / scPharmaceuticals Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Klaus R Dr Veitinger som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2021-06-11 2021-06-10 4 TCDA Tricida, Inc.
Stock Option (right to buy)
A - Award 57.235 57.235
2021-06-11 2021-06-10 4 TCDA Tricida, Inc.
Common Stock
A - Award 16.403 27.584 146,70
2021-06-10 2021-06-08 4 SCPH scPharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 16.300 16.300
2021-02-09 2020-08-10 5 TCDA Tricida, Inc.
Common Stock
G - Gift -35.804 11.181 -76,20
2020-06-15 2020-06-11 4 TCDA Tricida, Inc.
Stock Option (right to buy)
A - Award 22.967 22.967
2020-06-15 2020-06-11 4 TCDA Tricida, Inc.
Common Stock
A - Award 5.670 46.985 13,72
2020-06-11 2020-06-09 4 SCPH scPharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 6.124 6.124
2019-11-05 2019-11-01 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.750 0 -100,00
2019-11-05 2019-11-01 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 51.444 -3,29 38,87 -68.022 1.999.628
2019-11-05 2019-11-01 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 51.444 -3,29 38,88 -68.040 2.000.143
2019-11-05 2019-11-01 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 51.444 -3,29 38,88 -68.040 2.000.143
2019-11-05 2019-11-01 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.750 43.065 4,24 0,80 1.400 34.452
2019-10-29 2019-10-25 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.750 1.750 -50,00
2019-10-29 2019-10-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 53.194 -3,19 36,29 -63.508 1.930.410
2019-10-29 2019-10-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 53.194 -3,19 36,30 -63.525 1.930.942
2019-10-29 2019-10-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.750 41.315 -4,06 36,31 -63.542 1.500.148
2019-10-29 2019-10-25 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.750 43.065 4,24 0,80 1.400 34.452
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.400 3.500 -28,57
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -103 54.944 -0,19 32,47 -3.344 1.784.032
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -573 55.047 -1,03 32,12 -18.405 1.768.110
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -724 55.620 -1,28 30,72 -22.241 1.708.646
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -153 54.944 -0,28 32,42 -4.960 1.781.284
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -570 55.097 -1,02 32,01 -18.246 1.763.655
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -677 55.667 -1,20 30,72 -20.797 1.710.090
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -121 41.315 -0,29 32,45 -3.926 1.340.672
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -585 41.436 -1,39 32,05 -18.749 1.328.024
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -694 42.021 -1,62 30,66 -21.278 1.288.364
2019-09-30 2019-09-26 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.400 42.715 3,39 0,80 1.120 34.172
2019-08-28 2019-08-26 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.400 4.900 -22,22
2019-08-28 2019-08-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 56.344 -2,42 33,17 -46.438 1.868.930
2019-08-28 2019-08-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 56.344 -2,42 33,14 -46.396 1.867.240
2019-08-28 2019-08-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 41.315 -3,28 33,18 -46.452 1.370.832
2019-08-28 2019-08-26 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.400 42.715 3,39 0,80 1.120 34.172
2019-07-29 2019-07-25 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.400 6.300 -18,18
2019-07-29 2019-07-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 57.744 -2,37 31,64 -44.296 1.827.020
2019-07-29 2019-07-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 57.744 -2,37 31,62 -44.268 1.825.865
2019-07-29 2019-07-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.400 41.315 -3,28 31,61 -44.254 1.305.967
2019-07-29 2019-07-25 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.400 42.715 3,39 0,80 1.120 34.172
2019-07-09 2019-07-05 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -1.100 7.700 -12,50
2019-07-09 2019-07-05 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.200 59.144 -1,99 36,30 -43.560 2.146.927
2019-07-09 2019-07-05 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.192 59.144 -1,98 36,30 -43.270 2.146.927
2019-07-09 2019-07-05 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -1.100 41.315 -2,59 36,29 -39.919 1.499.321
2019-07-09 2019-07-05 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 1.100 42.415 2,66 0,80 880 33.932
2019-07-05 2019-07-03 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -3.100 8.800 -26,05
2019-07-05 2019-07-03 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.000 60.344 -4,74 36,91 -110.730 2.227.297
2019-07-05 2019-07-03 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.008 60.336 -4,75 36,89 -110.965 2.225.795
2019-07-05 2019-07-03 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.100 41.315 -6,98 36,91 -114.421 1.524.937
2019-07-05 2019-07-03 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 3.100 44.415 7,50 0,80 2.480 35.532
2019-06-20 2019-06-18 4 SCPH scPharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 6.124 6.124
2019-06-04 2019-05-31 4 TCDA Tricida, Inc.
Stock Option (right to buy)
A - Award 7.068 7.068
2019-06-04 2019-05-31 4 TCDA Tricida, Inc.
Common Stock
A - Award 1.879 41.315 4,76
2019-03-29 2019-03-28 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -22.100 11.900 -65,00
2019-03-29 2019-03-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -22.100 63.344 -25,86 34,18 -755.378 2.165.098
2019-03-29 2019-03-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -22.100 63.344 -25,86 34,19 -755.599 2.165.731
2019-03-29 2019-03-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -22.100 63.344 -25,86 34,19 -755.599 2.165.731
2019-03-29 2019-03-28 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 22.100 61.536 56,04 0,80 17.680 49.229
2019-03-28 2019-03-26 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -4.000 34.000 -10,53
2019-03-28 2019-03-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 85.444 -4,47 23,80 -95.200 2.033.567
2019-03-28 2019-03-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 85.444 -4,47 23,84 -95.360 2.036.985
2019-03-28 2019-03-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 39.436 -9,21 23,85 -95.400 940.549
2019-03-28 2019-03-26 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 4.000 43.436 10,14 0,80 3.200 34.749
2019-02-27 2019-02-25 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -4.000 38.000 -9,52
2019-02-27 2019-02-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 89.444 -4,28 22,59 -90.360 2.020.540
2019-02-27 2019-02-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 89.444 -4,28 22,60 -90.400 2.021.434
2019-02-27 2019-02-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -4.000 89.444 -4,28 22,60 -90.400 2.021.434
2019-02-27 2019-02-25 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 4.000 43.436 10,14 0,80 3.200 34.749
2019-01-30 2019-01-28 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -2.000 42.000 -4,55 0,80 -1.600 33.600
2019-01-30 2019-01-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 93.444 -2,10 20,33 -40.660 1.899.717
2019-01-30 2019-01-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 93.444 -2,10 20,32 -40.640 1.898.782
2019-01-30 2019-01-28 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 39.436 -4,83 20,29 -40.580 800.156
2019-01-30 2019-01-28 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 2.000 41.436 5,07 0,80 1.600 33.149
2019-01-28 2019-01-25 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -2.000 44.000 -4,35
2019-01-28 2019-01-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 95.444 -2,05 20,86 -41.720 1.990.962
2019-01-28 2019-01-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 95.444 -2,05 20,88 -41.760 1.992.871
2019-01-28 2019-01-25 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -2.000 39.436 -4,83 20,85 -41.700 822.241
2019-01-28 2019-01-25 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 2.000 41.436 5,07 0,80 1.600 33.149
2018-12-31 2018-12-27 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -997 46.000 -2,12
2018-12-31 2018-12-27 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -740 97.444 -0,75 23,74 -17.568 2.313.321
2018-12-31 2018-12-27 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -700 97.444 -0,71 23,78 -16.646 2.317.218
2018-12-31 2018-12-27 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -997 39.436 -2,47 23,63 -23.559 931.873
2018-12-31 2018-12-27 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 997 40.433 2,53 0,80 798 32.346
2018-12-28 2018-12-26 4 TCDA Tricida, Inc.
Stock Option (right to buy)
M - Exercise -3.254 46.997 -6,48
2018-12-28 2018-12-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.260 98.184 -3,21 24,97 -81.402 2.451.654
2018-12-28 2018-12-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.300 98.144 -3,25 24,97 -82.401 2.450.656
2018-12-28 2018-12-26 4 TCDA Tricida, Inc.
Common Stock
S - Sale X -3.254 39.436 -7,62 24,97 -81.252 984.717
2018-12-28 2018-12-26 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 3.254 42.690 8,25 0,80 2.603 34.152
2018-07-02 2018-07-02 4 TCDA Tricida, Inc.
Stock Option (right to buy)
A - Award 13.147 13.147
2018-07-02 2018-07-02 4 TCDA Tricida, Inc.
Common Stock
A - Award 3.632 39.436 10,14
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
274.496
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
274.496
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
274.496
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-27 3 TCDA Tricida, Inc.
Common Stock
340.136
2018-06-21 2018-06-19 4 SCPH scPharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 6.124 6.124
2015-11-27 2015-11-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 1.750 1.750
2015-11-27 2015-11-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 650 2.816 30,01
2015-11-12 2015-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -1.000 5.972 -14,34
2015-11-12 2015-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 2.166 -31,59 198,25 -198.250 429.410
2015-11-12 2015-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.000 3.166 46,17 21,50 21.500 68.069
2015-09-11 2015-09-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -500 6.972 -6,69
2015-09-11 2015-09-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -500 2.166 -18,75 198,25 -99.125 429.410
2015-09-11 2015-09-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 500 2.666 23,08 21,50 10.750 57.319
2015-08-05 2015-08-03 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -500 7.472 -6,27
2015-08-05 2015-08-03 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -500 2.166 -18,75 261,17 -130.585 565.694
2015-08-05 2015-08-03 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 500 2.666 23,08 21,50 10.750 57.319
2015-06-12 2015-06-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 7.972 -4,68
2015-06-12 2015-06-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -391 2.166 -15,29 238,21 -93.140 515.963
2015-06-12 2015-06-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2015-05-13 2015-05-11 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -5.834 69.543 -7,74
2015-05-13 2015-05-11 4 RLYP Relypsa Inc
Common Stock
S - Sale X -5.834 2.712 -68,27 36,06 -210.387 97.801
2015-05-13 2015-05-11 4 RLYP Relypsa Inc
Common Stock
M - Exercise 5.834 8.546 215,12 3,96 23.103 33.842
2015-05-13 2015-05-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 8.363 -4,47
2015-05-13 2015-05-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.166 -9,71 283,33 -66.016 613.694
2015-05-13 2015-05-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -158 2.399 -6,18 272,79 -43.101 654.423
2015-05-13 2015-05-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2015-04-14 2015-04-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 8.754 -4,28
2015-04-14 2015-04-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -391 2.166 -15,29 272,10 -106.391 589.369
2015-04-14 2015-04-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2015-04-13 2015-04-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -5.832 75.377 -7,18
2015-04-13 2015-04-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -5.832 2.712 -68,26 35,35 -206.179 95.877
2015-04-13 2015-04-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 5.832 8.544 215,04 3,96 23.095 33.834
2015-03-12 2015-03-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -2.503 81.209 -2,99
2015-03-12 2015-03-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -3.331 12.795 -20,66
2015-03-12 2015-03-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -5.834 2.712 -68,27 38,67 -225.594 104.870
2015-03-12 2015-03-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 2.503 8.546 41,42 3,96 9.912 33.842
2015-03-12 2015-03-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 3.331 6.043 122,82 4,65 15.489 28.100
2015-03-12 2015-03-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 9.145 -4,10
2015-03-12 2015-03-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -158 2.166 -6,80 263,25 -41.594 570.200
2015-03-12 2015-03-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.324 -9,11 261,25 -60.871 607.145
2015-03-12 2015-03-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2015-02-26 2015-02-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -632 9.536 -6,22
2015-02-26 2015-02-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -632 2.166 -22,59 222,50 -140.620 481.935
2015-02-26 2015-02-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 632 2.798 29,18 21,50 13.588 60.157
2015-02-12 2015-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -233 10.168 -2,24
2015-02-12 2015-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.166 -9,71 195,52 -45.556 423.496
2015-02-12 2015-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 233 2.399 10,76 21,50 5.010 51.578
2015-02-10 2015-02-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -5.834 16.126 -26,57
2015-02-10 2015-02-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -100 2.712 -3,56 32,74 -3.274 88.791
2015-02-10 2015-02-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -5.734 2.812 -67,10 32,10 -184.085 90.277
2015-02-10 2015-02-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 5.834 8.546 215,12 4,65 27.128 39.739
2015-01-14 2015-01-12 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -5.834 21.960 -20,99
2015-01-14 2015-01-12 4 RLYP Relypsa Inc
Common Stock
S - Sale X -1.448 2.712 -34,81 32,79 -47.483 88.932
2015-01-14 2015-01-12 4 RLYP Relypsa Inc
Common Stock
S - Sale X -4.386 4.160 -51,32 32,17 -141.106 133.835
2015-01-14 2015-01-12 4 RLYP Relypsa Inc
Common Stock
M - Exercise 5.834 8.546 215,12 4,65 27.128 39.739
2015-01-14 2015-01-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -233 10.401 -2,19
2015-01-14 2015-01-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.166 -9,71 150,01 -34.952 324.922
2015-01-14 2015-01-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 233 2.399 10,76 21,50 5.010 51.578
2014-12-12 2014-12-12 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -9.852 27.794 -26,17
2014-12-12 2014-12-12 4 RLYP Relypsa Inc
Common Stock
S - Sale X -9.852 2.712 -78,41 32,50 -320.190 88.140
2014-12-12 2014-12-12 4 RLYP Relypsa Inc
Common Stock
M - Exercise 9.852 12.564 363,27 4,65 45.812 58.423
2014-12-12 2014-12-11 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -150 37.646 -0,40
2014-12-12 2014-12-11 4 RLYP Relypsa Inc
Common Stock
S - Sale X -150 2.712 -5,24 32,50 -4.875 88.140
2014-12-12 2014-12-11 4 RLYP Relypsa Inc
Common Stock
M - Exercise 150 2.862 5,53 4,65 698 13.308
2014-12-12 2014-12-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -4.167 37.796 -9,93
2014-12-12 2014-12-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -263 2.712 -8,84 32,20 -8.468 87.324
2014-12-12 2014-12-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -3.104 2.975 -51,06 31,52 -97.841 93.775
2014-12-12 2014-12-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -800 6.079 -11,63 30,38 -24.307 184.703
2014-12-12 2014-12-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 4.167 6.879 153,65 4,65 19.377 31.987
2014-12-12 2014-12-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -233 10.634 -2,14
2014-12-12 2014-12-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.166 -9,71 144,16 -33.589 312.251
2014-12-12 2014-12-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 233 2.399 10,76 21,50 5.010 51.578
2014-11-24 2014-11-20 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -3.334 41.963 -7,36
2014-11-24 2014-11-20 4 RLYP Relypsa Inc
Common Stock
S - Sale X -3.334 2.712 -55,14 22,50 -75.015 61.020
2014-11-24 2014-11-20 4 RLYP Relypsa Inc
Common Stock
M - Exercise 3.334 6.046 122,94 4,65 15.503 28.114
2014-11-12 2014-11-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -2.500 45.297 -5,23
2014-11-12 2014-11-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -2.500 2.712 -47,97 20,06 -50.144 54.396
2014-11-12 2014-11-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 2.500 5.212 92,18 4,65 11.625 24.236
2014-11-12 2014-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -233 10.867 -2,10
2014-11-12 2014-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 2.166 -9,71 175,95 -40.996 381.108
2014-11-12 2014-11-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 233 2.399 10,76 21,50 5.010 51.578
2014-10-15 2014-10-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 11.100 -3,40
2014-10-15 2014-10-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -391 2.166 -15,29 223,65 -87.447 484.426
2014-10-15 2014-10-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2014-10-15 2014-10-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -2.500 47.797 -4,97
2014-10-15 2014-10-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -100 2.712 -3,56 19,86 -1.986 53.860
2014-10-15 2014-10-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -2.400 2.812 -46,05 19,32 -46.357 54.315
2014-10-15 2014-10-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 2.500 5.212 92,18 4,65 11.625 24.236
2014-09-12 2014-09-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -391 11.491 -3,29
2014-09-12 2014-09-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -391 2.166 -15,29 280,50 -109.676 607.563
2014-09-12 2014-09-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2014-09-11 2014-09-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -4.167 50.297 -7,65
2014-09-11 2014-09-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -4.167 2.712 -60,58 23,00 -95.851 62.383
2014-09-11 2014-09-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 4.167 6.879 153,65 4,65 19.377 31.987
2014-08-15 2014-08-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise X -316 11.882 -2,59
2014-08-15 2014-08-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -316 2.166 -12,73 345,62 -109.216 748.613
2014-08-15 2014-08-12 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 316 2.482 14,59 21,50 6.794 53.363
2014-08-12 2014-08-11 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -4.167 54.464 -7,11
2014-08-12 2014-08-11 4 RLYP Relypsa Inc
Common Stock
S - Sale X -4.167 2.712 -60,58 27,73 -115.563 75.212
2014-08-12 2014-08-11 4 RLYP Relypsa Inc
Common Stock
M - Exercise 4.167 6.879 153,65 4,65 19.377 31.987
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
M - Exercise -391 12.198 -3,11
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -391 2.166 -15,29 239,49 -93.641 518.735
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.557 18,05 21,50 8.406 54.976
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -1 2.166 -0,05 238,28 -238 516.114
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -93 2.167 -4,12 238,26 -22.158 516.309
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -6 2.260 -0,26 238,25 -1.430 538.445
2014-08-12 2014-08-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -64 2.266 -2,75 234,71 -15.021 531.853
2014-08-12 2014-08-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -324 0 -100,00
2014-08-12 2014-08-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 324 2.330 16,15
2014-07-21 2014-07-17 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 275 275
2014-07-21 2014-07-17 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 226 2.006 12,70
2014-07-11 2014-07-10 4 RLYP Relypsa Inc
Stock Option (right to buy)
M - Exercise -4.167 58.631 -6,64
2014-07-11 2014-07-10 4 RLYP Relypsa Inc
Common Stock
S - Sale X -4.167 2.712 -60,58 23,12 -96.354 62.710
2014-07-11 2014-07-10 4 RLYP Relypsa Inc
Common Stock
M - Exercise 4.167 6.879 153,65 4,65 19.377 31.987
2014-07-11 2014-07-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise X -391 12.589 -3,01
2014-07-11 2014-07-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -158 1.780 -8,15 222,50 -35.155 396.050
2014-07-11 2014-07-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -233 1.938 -10,73 216,88 -50.533 420.313
2014-07-11 2014-07-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise X 391 2.171 21,97 21,50 8.406 46.676
2014-06-23 2014-06-19 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 3.828 3.828
2014-06-23 2014-06-19 4 RLYP Relypsa Inc
Common Stock
A - Award 2.712 2.712
2014-05-09 2014-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -325 324 -50,08
2014-05-09 2014-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 1.780 -5,32 232,35 -23.235 413.587
2014-05-09 2014-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -62 1.880 -3,19 228,69 -14.179 429.937
2014-05-09 2014-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 325 1.942 20,10
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -65 1.617 -3,86 251,25 -16.331 406.271
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 1.682 -5,61 250,46 -25.046 421.274
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 1.782 -5,31 252,31 -25.231 449.616
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 1.882 -5,05 255,91 -25.591 481.623
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 1.982 -4,80 254,00 -25.400 503.428
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 2.082 -4,58 254,09 -25.409 529.015
2014-05-09 2014-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 2.182 -4,38 261,42 -26.142 570.418
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -52 2.282 -2,23 385,04 -20.022 878.661
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -1 2.334 -0,04 385,00 -385 898.590
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -1 2.335 -0,04 384,77 -385 898.438
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -7 2.336 -0,30 384,33 -2.690 897.795
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -1 2.343 -0,04 374,09 -374 876.493
2014-02-11 2014-02-10 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 2.344 -4,09 373,34 -37.334 875.109
2014-02-11 2014-02-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -324 649 -33,30
2014-02-11 2014-02-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 324 2.444 15,28
2013-11-12 2013-11-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -100 2.120 -4,50 49,01 -4.901 103.901
2013-11-12 2013-11-11 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -62 2.220 -2,72 48,81 -3.026 108.358
2013-11-12 2013-11-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -325 973 -25,04
2013-11-12 2013-11-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 325 2.282 16,61
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -71 1.957 -3,50 75,00 -5.325 146.775
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.028 -4,70 74,89 -7.489 151.877
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.128 -4,49 74,76 -7.476 159.100
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.228 -4,30 74,25 -7.425 165.429
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.328 -4,12 73,57 -7.357 171.271
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.428 -3,96 72,64 -7.264 176.358
2013-10-03 2013-10-01 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
S - Sale X -100 2.528 -3,81 69,26 -6.926 175.077
2013-08-13 2013-08-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -325 1.298 -20,02
2013-08-13 2013-08-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 325 2.628 14,11
2013-05-09 2013-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -324 1.623 -16,64
2013-05-09 2013-05-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
M - Exercise 324 973 49,92
2013-05-09 2013-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
A - Award 1.980 1.980
2013-05-09 2013-05-07 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 1.330 2.303 136,69
2013-04-11 2013-04-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -649 1.947 -25,00
2013-04-11 2013-04-09 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common stock
M - Exercise 649 649
2012-11-20 2012-11-16 4 ICPT INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock
A - Award 12.980 12.980
2012-11-20 2012-11-16 4 ICPT INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2.596 2.596
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)